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eMethods. Statistical models
The mixed effects (random-coefficient) model used to estimate smooth baseline BMI trajectories is: 
where aij is longitudinal age of participant i at baseline time j (centered at 44 y), si is the sex of subject i (coded 0 for males, 1 for females), and ai0 is age at entry (centered at 35 y), with
(0, ) and ~,diag k ij NN ς 0 ("~" denotes "is distributed as"). We also assessed the effect of radiation dose (ei) as a further predictor in the level 1 model, as noted in the methods section of the main paper, but radiation dose was not retained in the final analysis as it had no effect. The level 1 model specifies how BMI depends on age (i.e. a polynomial model) for a given subject, as well as how BMI depends on other covariates that are fixed within each subject (age at entry into the study and sex). The level 2 model specifies the random effects (coefficients of the longitudinal BMI trajectory), allowing for those coefficients to vary among subjects. The linear random-coefficient model used to derive overall BMI level and slope random effects is model (e1) with only the first two terms in the level 2 model. 
